It has been proposed that T-bet+ IgG+ MBCs expressing CXCR3 are induced by reactivation of EBV infection and preferentially recruited to the CNS of patients with MS where they act as APCs for pathogenic T cells (2, 12, 14). This evidence concerns the gene CXCR3 and myeloid sarcoma.